Isolation of the novel phage SAP71 and its potential use against Staphylococcus aureus in an atopic dermatitis mouse model
- 5 September 2024
- journal article
- research article
- Published by Springer Nature in Virus Genes
- Vol. 60 (6) , 737-746
Abstract
Atopic dermatitis (AD) is accompanied by changes in skin microbiota, in which abnormal colonization of Staphylococcus aureus is particularly common. The antibiotic treatment is prone to destroy the commensal bacterial community, further exacerbating the microbiome dysbiosis. Elimination of S. aureus through phage-targeted therapies presents a promising method in the treatment strategy of AD. In this study, we isolated a novel phage SAP71, which specifically lysed S. aureus. Genome sequencing showed that SAP71 contained no virulence, lysogenic, or antimicrobial resistance genes, making this lytic phage a potential agent for phage therapy. Moreover, we demonstrated that phage SAP71 was able to significantly improve the skin lesions, reduce the bacterial loads in the skin, and prevent the development of AD-like skin pathological changes in an AD model. In short, phage SAP71 was demonstrated to effectively treat S. aureus infection in AD, which provided a theoretical basis for the clinical phage therapy of AD.Keywords
Funding Information
- the Natural Science Foundation of Sichuan Province (No. 2022NSFSC0755, No. 2022NSFSC0755, No. 2022NSFSC0755, No. 2022NSFSC0755, No. 2022NSFSC0755, No. 2022NSFSC0755, No. 2022NSFSC0755, No. 2022NSFSC0755, No. 2022NSFSC0755, No. 2022NSFSC0755)
This publication has 41 references indexed in Scilit:
- S. aureus drives itch and scratch-induced skin damage through a V8 protease-PAR1 axisCell, 2023
- Phage therapy: From biological mechanisms to future directionsCell, 2023
- Targeted suppression of human IBD-associated gut microbiota commensals by phage consortia for treatment of intestinal inflammationCell, 2022
- Host and pathogen response to bacteriophage engineered against Mycobacterium abscessus lung infectionCell, 2022
- Skin bacterial transplant in atopic dermatitis: Knowns, unknowns and emerging trendsJournal of Dermatological Science, 2019
- The microbiome in patients with atopic dermatitisJournal of Allergy and Clinical Immunology, 2019
- Bacterial and Viral Infections in Atopic Dermatitis: a Comprehensive ReviewClinical Reviews in Allergy & Immunology, 2016
- Staphylococcus aureus density on lesional and nonlesional skin is strongly associated with disease severity in atopic dermatitisJournal of Allergy and Clinical Immunology, 2016
- Recurrent MRSA Skin Infections in Atopic DermatitisThe Journal of Allergy and Clinical Immunology: In Practice, 2014
- Phage therapy to control multidrug-resistant Pseudomonas aeruginosa skin infections: in vitro and ex vivo experimentsEuropean Journal of Clinical Microbiology & Infectious Diseases, 2012